Lataa...
Long term survival in a patient with variant Creutzfeldt–Jakob disease treated with intraventricular pentosan polysulphate
Variant Creutzfeldt‐Jakob disease (vCJD) is a neurodegenerative disease that principally affects young people and has a median duration of illness of 13 (range 6–39) months. vCJD is incurable and there are currently no treatments that conclusively slow the rate of disease progression. However, recen...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Group
2007
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2117700/ https://ncbi.nlm.nih.gov/pubmed/17314188 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp.2006.104505 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|